As Prices Rise for Parkinson's, Alzheimer's Meds, Patients Go Without

WEDNESDAY, Feb. 19, 2020 — Rising drug costs are hampering the care of patients with debilitating neurological disorders like Parkinson’s disease and Alzheimer’s, a new study finds.
Patients are less likely to fill necessary prescriptions as…
Source: Topamax